drugset / Trial / NCT00002928

Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer

NCT00002928 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients with recurrent or progressive advanced epithelial ovarian cancer following previous paclitaxel.

Timeline

Start
1997-01
Primary completion
2001-08
Completion
2001-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule — Intravenous

Indications